does tirzepatide help with addiction A turning point in psychiatry? | School of Public Health GLP-1 drugs may fight addiction

Overall, success with Zepbound requires commitment to a lower-calorie diet and regular exercise

U.TakatsukaT.MiyamotoS.SasakiM.et al

This case raises important concerns about a possible gastrointestinal adverse effect associated with the use of GLP-1RAs

Novo Nordisk's SELECT trial published in 2023, set a high standard by demonstrating that Wegovy-induced weight loss led to a statistically significant 20% reduction in a composite endpoint comprising cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke among overweight or obese patients with prior cardiovascular disease

This makes it an excellent supplement for those focused on improving overall body composition